Orexin/hypocretin is necessary for context-driven cocaine-seeking

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 179-184

  Smith, Rachel J ^a   Tahsili Fahadan, Pouya ^a   Aston Jones, Gary ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Abstinence; Addiction; Cocaine; Orexin; Reinstatement; Self administration

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; COCAINE; OREXIN; OREXIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CAGE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; EXPERIMENTAL DESIGN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BENZOXAZOLES; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TIME FACTORS; UREA;

EID: 71549139716     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.042     Document Type: Article

References (43)

1. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
2. Bouton M.E., and Bolles R.C. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J. Exp. Psychol. Anim. Behav. Process. 5 (1979) 368-378
3. Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br. J. Pharmacol. 154 (2008) 343-357
4. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., and de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19168-19173
5. Crombag H.S., and Shaham Y. Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behav. Neurosci. 116 (2002) 169-173
6. Crombag H.S., Grimm J.W., and Shaham Y. Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 27 (2002) 1006-1015
7. Dayas C.V., McGranahan T.M., Martin-Fardon R., and Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol. Psychiatry 63 (2008) 152-157
8. Dugovic C., Shelton J.E., Aluisio L.E., Fraser I.C., Jiang X., Sutton S.W., Bonaventure P., Yun S., Li X., Lord B., Dvorak C.A., Carruthers N.I., and Lovenberg T.W. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J. Pharmacol. Exp. Ther. (2009)
9. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005) 1481-1489
10. Fuchs R.A., Evans K.A., Parker M.C., and See R.E. Differential involvement of the core and shell subregions of the nucleus accumbens in conditioned cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl.) 176 (2004) 459-465
11. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., and See R.E. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30 (2005) 296-309
12. Fuchs R.A., Branham R.K., and See R.E. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J. Neurosci. 26 (2006) 3584-3588
13. Fuchs R.A., Ramirez D.R., and Bell G.H. Nucleus accumbens shell and core involvement in drug context-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl.) 200 (2008) 545-556
14. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., Yanagisawa M., Nestler E.J., and DiLeone R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23 (2003) 3106-3111
15. Grimm J.W., Hope B.T., Wise R.A., and Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412 (2001) 141-142
16. Hamlin A.S., Clemens K.J., and McNally G.P. Renewal of extinguished cocaine-seeking. Neuroscience 151 (2008) 659-670
17. Harris G.C., and Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29 (2006) 571-577
18. Harris G.C., Wimmer M., and Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
19. Harris G.C., Wimmer M., Randall-Thompson J.F., and Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res. 183 (2007) 43-51
20. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., and Oldfield B. The orexin system regulates alcohol-seeking in rats. Br. J. Pharmacol. 148 (2006) 752-759
21. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett II F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., and Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 322-327
22. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
23. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., and Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435 (2001) 6-25
24. McLaughlin J., and See R.E. Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 168 (2003) 57-65
25. Meil W.M., and See R.E. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav. Pharmacol. 7 (1996) 754-763
26. Meil W.M., and See R.E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav. Brain Res. 87 (1997) 139-148
27. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., and Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26 (2006) 398-405
28. O'Brien C.P. A range of research-based pharmacotherapies for addiction. Science 278 (1997) 66-70
29. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., and Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl.) 199 (2008) 109-117
30. Rogers J.L., and See R.E. Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol. Learn. Mem. 87 (2007) 688-692
31. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
32. See R.E., Kruzich P.J., and Grimm J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl.) 154 (2001) 301-310
33. See R.E., Elliott J.C., and Feltenstein M.W. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology (Berl.) 194 (2007) 321-331
34. Self D.W., Choi K.H., Simmons D., Walker J.R., and Smagula C.S. Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn. Mem. 11 (2004) 648-657
35. Siegel J.M. Hypocretin (orexin): role in normal behavior and neuropathology. Annu. Rev. Psychol. 55 (2004) 125-148
36. Sinha R., Fuse T., Aubin L.R., and O'Malley S.S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl.) 152 (2000) 140-148
37. Smith R.J., and Aston-Jones G. The Orexin/Hypocretin 1 Receptor Antagonist SB-334867 Reduces Cocaine-seeking in Rats After 1 or 14 Days of Abstinence. Neuroscience Meeting Planner Online, Program No. 63.14 (2008), Society for Neuroscience, Washington, DC
38. Smith M.I., Piper D.C., Duxon M.S., and Upton N. Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci. Lett. 341 (2003) 256-258
39. 1 receptor regulates cue-elicited cocaine-seeking. Eur. J. Neurosci., in press.
40. Tahsili-Fahadan P., and Aston-Jones G. Involvement of Orexin (Hypocretin) Pathway in Context-induced Reinstatement of Cocaine-seeking in Rats. Neuroscience Meeting Planner Online (2009), Society for Neuroscience, Chicago, IL
41. Tran-Nguyen L.T., Fuchs R.A., Coffey G.P., Baker D.A., O'Dell L.E., and Neisewander J.L. Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19 (1998) 48-59
42. Wallace B.C. Psychological and environmental determinants of relapse in crack cocaine smokers. J. Subst. Abuse Treat. 6 (1989) 95-106
43. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., Leonard C.S., Richardson J.A., Hammer R.E., and Yanagisawa M. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38 (2003) 715-730